EtOH/Ba(OH)2
1711
chromatography (silica gel, 100–200 mesh) and eluted with 10% EtOAc–
hexanes to give 2a (63 mg, 12%) as a crystalline solid. Mp 184–1868C;
Rf ¼ 0.43 (10% EtOAc–hexanes); IR (KBr) 3466, 1683, 1596, 1449, 1258,
709, 691 cm21
;
1H NMR (300 MHz, CDCl3) d 0.68 (t, J ¼ 7.2 Hz, 3H),
2.85 (m, 1H), 3.09 (m, 1H), 4.20 (s, 1H), 4.49 (d, J ¼ 7.8 Hz, 1H), 4.55
(d, J ¼ 10.5 Hz, 1H), 4.78 (dd, J ¼ 7.8, 10.5 Hz, 1H), 5.76 (t, J ¼ 10.2 Hz,
1H), 7.05 (t, J ¼ 7.8 Hz, 2H), 7.21–7.54 (m, 14H), 7.89 (d, J ¼ 8.7 Hz,
2H), 8.26 (d, J ¼ 8.7 Hz, 2H) ppm; 13C NMR (75 MHz, CDCl3) d 14.6,
46.1, 54.8, 62.3, 68.9, 82.7, 89.7, 124.8, 127.3, 127.8, 128.0, 128.3, 128.5
(2C), 128.6, 129.4, 132.4, 133.1, 133.6, 136.2, 137.2, 137.3, 144.7, 196.9,
197.5, 202.5 ppm; FAB-MS 519 (Mþ þ 1); Anal. calcd. for C34H30O5:
C, 78.74; H, 5.83. Found: C, 78.77; H, 5.87.
(+) (4-Chlorophenyl)[(1R,2S,3S,4S,5R)-4,5-di(4-chlorobenzoyl)-3-(4-chloro-
phenyl)-2-ethoxy-3-hydroxycyclopentyl]methanone 2b: Mp 168–1708C;
Rf ¼ 0.36 (10% EtOAc–hexanes); IR (KBr) 3466, 2975, 2929, 1684, 1588,
1489, 1401, 1247, 1093, 1006, 840 cm21 1H NMR (300 MHz, CDCl3/
;
CCl4) d 0.76 (t, J ¼ 6.9 Hz, 3H), 2.81–2.91 (m, 1H), 3.06–3.16 (m, 1H),
4.04 (s, 1H), 4.30 (d, J ¼ 10.8 Hz, 1H), 4.35 (d, J ¼ 9.9 Hz, 1H), 4.60
(t, J ¼ 7.5 Hz, 1H), 5.56 (t, J ¼ 10.2 Hz, 1H), 7.07 (d, J ¼ 8.4 Hz, 2H), 7.24
(d, J ¼ 8.1 Hz, 2H), 7.31 (d, J ¼ 8.1 Hz, 2H), 7.39–7.50 (m, 6H), 7.81
(d, J ¼ 8.4 Hz, 2H), 8.16 (d, J ¼ 8.4 Hz, 2H) ppm; 13C NMR (75 MHz,
CDCl3/CCl4) d 14.98, 45.86, 54.60, 62.44, 69.04, 82.53, 89.73, 126.38,
128.29, 129.00, 129.15, 129.51, 129.77, 130.21, 131.15, 133.87, 134.29,
135.50, 135.61, 139.33, 139.87, 140.63, 143.37, 194.65, 195.09,
200.72 ppm; LRMS Mþ did not appear, 639 (7), 517 (19), 515 (30), 497
(18), 468 (29), 447 (15), 445 (35), 443 (27), 428 (20), 364 (31), 348 (24),
348 (18), 307 (69), 305 (100), 304 (74), 181 (12), 183 (7), 113 (27), 111
(78), 89 (19), 75 (55), 69 (18); Anal. calcd. for C34H24Cl4O5: C, 62.24;
H, 3.99. Found: C, 62.21; H, 4.02.
(+) (4-Bromophenyl)[(1R,2S,3S,4S,5R)-4,5-di(4-bromobenzoyl)-3-(4-bromo-
phenyl)-2-ethoxy-3-hydroxycyclopentyl]methanone 2c: Mp 176–1788C;
Rf ¼ 0.38 (10% EtOAc–hexanes); IR (KBr) 3496, 2971, 2927, 1671, 1585,
1
1486, 1398, 1234, 1096, 1073, 1003, 980, 834 cm21; H NMR (300 MHz,
CDCl3/CCl4) d 0.71 (t, J ¼ 14.1 Hz, 3H), 2.82–2.92 (m, 1H), 3.03–3.13
(m, 1H), 4.07 (s, 1H), 4.36 (d, J ¼ 10.8 Hz, 1H), 4.41 (d, J ¼ 7.8 Hz, 1H),
4.62 (t, J ¼ 18.0 Hz, 1H), 5.61 (t, J ¼ 20.4 Hz, 1H), 7.17 (d, J ¼ 7.5 Hz,
2H), 7.25 (d, J ¼ 8.1 Hz, 2H), 7.38 (d, J ¼ 8.1 Hz, 2H), 7.46 (d, J ¼ 8.7 Hz,
2H), 7.60 (dd, J ¼ 6.3, 4.8 Hz, 4H), 7.74 (d, J ¼ 8.4 Hz, 2H), 8.11
(d, J ¼ 8.4 Hz, 2H) ppm; 13C NMR (75 MHz, CDCl3/CCl4) d 14.64, 45.81,
54.56, 62.29, 69.14, 82.40, 89.32, 121.74, 126.60, 127.94 (2C), 128.55
(2C), 129.44, 129.64, 130.97, 131.23, 131.84, 131.96, 132.11, 134.71,
135.91, 143.41, 195.42, 196.10, 201.24 ppm; LRMS Mþ peak did not